$ITMN News 6 stocks to watch 3:25 p.m. May 29, 2014 -

New Post Public Reply Private Reply Replies (0) Message Board

Jun 4, 2014 at 10:44 AM

$ITMN News

6 stocks to watch 3:25 p.m. May 29, 2014 - The Trading Deck
Charting the Nasdaq’s technical breakout 12:34 p.m. May 27, 2014 - Michael Ashbaugh
Charting the Nasdaq’s technical breakout 12:05 p.m. May 27, 2014 - Michael Ashbaugh
6 stocks to watch 3:25 p.m. May 7, 2014 - The Trading Deck
InterMune slips off lofty perch while Aegerion's earnings disappoint 12:26 p.m. Feb. 26, 2014 - Russ Britt
'Bad' weather heads west, retailers report, and don't short addiction 8:06 a.m. Feb. 26, 2014 - Shawn Langlois
InterMune's big day lifts ETF, biotech index to record highs 5:44 p.m. Feb. 25, 2014 - Russ Britt
InterMune shares more than double on tests for lung-disease treatment 12:27 p.m. Feb. 25, 2014 - Russ Britt
Biogen, InterMune, Alkermes all make stock waves with earnings 2:28 p.m. July 25, 2013 - Russ Britt
Hedge funds are buying these stocks 4:41 p.m. April 26, 2013 - Insider Monkey
Market post-mortem: Big biotechs spike as Street warming to firms 5:43 p.m. April 12, 2013 - Russ Britt
InterMune shares jump after U.K. regulator recommends key drug 10:44 a.m. March 21, 2013 - Russ Britt
Thursday’s biggest movers; Apple at 5-month low 6:27 p.m. Nov. 8, 2012 - Sue Chang
Wednesday’s biggest gaining and declining stocks 4:32 p.m. Oct. 3, 2012 - MarketWatch
Stocks to watch Tuesday: Nordson, Georgia Gulf 6:40 a.m. May 22, 2012 - MarketWatch
Monday’s biggest gaining and declining stocks 4:19 p.m. April 9, 2012 - Kate Gibson
InterMune: Light at the end of the tunnel? 3:31 p.m. April 9, 2012 - blogs.marketwatch.com
InterMune tumbles on study update 12:27 p.m. April 9, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining & declining stocks 4:34 p.m. March 15, 2012 - Kate Gibson
InterMune climbs on German regulatory update 12:28 p.m. March 15, 2012 - Val Brickates Kennedy

InterMune Resubmits Esbriet NDA - Analyst Blog 6:18 p.m. May 28, 2014 - Zacks.com
Isis Shines, PTC Therapeutics Soars - Analyst Blog 11:16 a.m. May 28, 2014 - Zacks.com
Intermune resubmits NDA 8:24 a.m. May 27, 2014 - Seeking Alpha
Jim Cramer's Top Stock Picks: ITMN CAB SPWH DKS OPK YHOO 6:00 a.m. May 23, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: What Was Bad Is Good Again 7:54 p.m. May 22, 2014 - TheStreet.com
Additional Data on InterMune's Esbriet - Analyst Blog 5:05 p.m. May 21, 2014 - Zacks.com
Biotech Stock Roundup: Celldex, Incyte Tie Up with Big Pharma for Immuno-Oncology - Analyst Blog 9:22 a.m. May 21, 2014 - Zacks.com
InterMune Up on Esbriet Data Presentation - Analyst Blog 4:30 p.m. May 20, 2014 - Zacks.com
InterMune Offers Added Pirfenidone Data in Idiopathic Pulmonary Fibrosis, Says Endpoint Was Met with Statistical Significance in Capacity 2 4:03 p.m. May 20, 2014 - benzinga.com
InterMune (ITMN) Jumps: Stock Moves 13.4% Higher - Tale of the Tape 9:25 a.m. May 20, 2014 - Zacks.com
Why InterMune (ITMN) Stock Surged to a One-Year High Today 2:16 p.m. May 19, 2014 - TheStreet.com
Jim Cramer's Stop Trading: InterMune Shoots Higher, Zillow Could Too 11:15 a.m. May 19, 2014 - TheStreet.com
UPDATE: Investors Bullish On InterMune After Leerlink Upgrade 10:50 a.m. May 19, 2014 - benzinga.com
InterMune Higher on Superior Lung Drug Data, FDA Resubmission Next 10:39 a.m. May 19, 2014 - TheStreet.com
Benzinga's Volume Movers 9:27 a.m. May 19, 2014 - benzinga.com
Will This Analyst Upgrade Help InterMune (ITMN) Stock Today? 9:20 a.m. May 19, 2014 - TheStreet.com
Morning Market Movers 8:45 a.m. May 19, 2014 - benzinga.com
Benzinga's Top #PreMarket Gainers 7:08 a.m. May 19, 2014 - benzinga.com
Pirfenidone Phase 3 achieves primary endpoint 10:53 p.m. May 18, 2014 - Seeking Alpha
Lung Drug Data Showdown: InterMune vs. Boehringer Ingelheim 5:05 p.m. May 18, 2014 - TheStreet.com

Critical Alerts For Macy's, Western Digital, InterMune, Merck, and Time Warner Released By InvestorsObserver 9:31 a.m. May 28, 2014 - PR Newswire - PRF
InterMune Announces Resubmission Of NDA For Pirfenidone For The Treatment Of Patients With IPF 7:00 a.m. May 27, 2014 - PR Newswire - PRF
Study Results, Extension of Supply Agreements, Drug Designations, Senior Level Appointments, and Upcoming Events - Analyst Notes on InterMune, Actavis, Bristol-Myers, AbbVie and Illumina 8:30 a.m. May 22, 2014 - PR Newswire - PRF
InterMune Announces Additional Pirfenidone Data in Idiopathic Pulmonary Fibrosis 5:00 p.m. May 20, 2014 - PR Newswire - PRF
Morning Coverage of Equities Reaching New Highs -- Research on InterMune, Zillow, ICICI Bank, and Zendesk 11:14 a.m. May 20, 2014 - PR Newswire - PRF
Phase 3 ASCEND Study of Pirfenidone in Idiopathic Pulmonary Fibrosis Presented at American Thoracic Society (ATS) and Published in New England Journal of Medicine 5:02 p.m. May 18, 2014 - PR Newswire - PRF
IDIOPATHIC PULMONARY FIBROSIS PATIENTS TO HAVE EXPANDED ACCESS TO THERAPY 8:12 a.m. May 16, 2014 - GlobeNewswire
InterMune Announces Expanded Access Program for Pirfenidone to Treat Idiopathic Pulmonary Fibrosis (IPF) in the United States 8:00 a.m. May 16, 2014 - PR Newswire - PRF
InterMune Announces Upcoming Data Presentations at 2014 American Thoracic Society Meeting 8:00 a.m. May 12, 2014 - PR Newswire - PRF
InterMune Reports First Quarter 2014 Financial Results, Clinical Development and Business Highlights 4:01 p.m. May 1, 2014 - PR Newswire - PRF
InterMune To Release First Quarter Financial Results On May 1 8:00 a.m. April 23, 2014 - PR Newswire - PRF
Approved Equities, Voluntary Recall, and New Product Launches - Analyst Notes on Baxter, Agilent, InterMune, Intuitive Surgical, and Mindray 8:00 a.m. March 14, 2014 - PR Newswire - PRF
InterMune Announces Pricing of Public Offering of 7,500,000 Shares of Common Stock 7:20 p.m. March 13, 2014 - PR Newswire - PRF
InterMune Announces Proposed Public Offering of Common Stock 4:02 p.m. March 12, 2014 - PR Newswire - PRF
Top Gainers under the Lens: Advanced Micro Devices, Big Lots, InterMune, and Palo Alto Networks 1:38 p.m. March 10, 2014 - PR Newswire - PRF
Cannabis & Biotech Advancers Forging Ahead - Company Contracts With One of The Oldest Marijuana Dispensaries in California 9:05 a.m. March 10, 2014 - PR Newswire - PRF
Critical Alerts For InterMune, Infinity Pharmaceuticals, Zulily, Intrexon, and Polypore International Released By InvestorsObserver 10:31 a.m. Feb. 26, 2014 - PR Newswire - PRF
Consensus Earnings Forecast for BlackBerry, AT&T, Micron, InterMune, RF Micro Devices, and Coca-Cola 10:00 a.m. Feb. 26, 2014 - PR Newswire - PRF
Office Depot Offers Disappointing Outlook; InterMune Soars 170% to Record High on Phase 3 Test Results 1:25 a.m. Feb. 26, 2014 - ACCESSWIRE
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF) 8:00 a.m. Feb. 25, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Machine Grabs Prime Dallas Property Amid Apartment Boom

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

FJBio Boosts Antibody Discovery with Sapio AI

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Cracking the Code of America's Delivery Addiction

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Anecdotes by Artists Brings Raw Scent Stories to Sephora

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

K-Beauty Takes Front Stage at Target Beauty Studio

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Leapora's Taskeen: Redefining Task Accountability

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

FutureVault's AI Agents: Transforming Financial Workflows

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Compass Unveiled: Power Revolution in Private Equity

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Sean Trahan Joins Citrin Cooperman: New Tax Lead

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...